MD Anderson Cancer Center
Leukemia (AML/MDS) Moon Shots update - CNL
Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce enough blood cells. MD Anderson Cancer Center is the world’s largest practice for treating AML and MDS. Guillermo Garcia-Manero, M.D., professor in Leukemia at MD Anderson, discusses milestones made with this MD Anderson moon shots, including new research with immunotherapy and ways to make stem cell transplantation less toxic.

Transcript Transcript     Accessibility shortcut keys (H) Shortcuts
Loading the Audio Player...

Title: Leukemia (AML/MDS) Moon Shots update - CNL
Summary: Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce enough blood cells. MD Anderson Cancer Center is the world’s largest practice for treating AML and MDS. Guillermo Garcia-Manero, M.D., professor in Leukemia at MD Anderson, discusses milestones made with this MD Anderson moon shots, including new research with immunotherapy and ways to make stem cell transplantation less toxic.
Keywords: cnl, cancer newsline, Myeloid leukemia, while myelodysplastic syndromes, mds, aml, leukemia, moon shot, Garcia-manero, research, immunotherapy, stem cell transplant, bone marrow, cancer, blood
Transcript: http://www.mdanderson.org/transcripts/cancer-newsline/2014/leukemia-aml---mds-moon-shots-update-6-30-14.htm